Skip to content
Aperlena
Language:

Germany - Medicines - Pharmaceutical contracts with option to accede

Original Deutschland - Arzneimittel - Arzneimittelverträge mit Beitrittsoption

Open Contract notice 499 days left
Watch this tender

Deadline 1 Feb. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 18 Jan, questions by 18 Jan, draft by 25 Jan. Log in

  1. Published
  2. Today
  3. Deadline open for 679 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 3 different companies have won the last 3 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Based on 3 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

This notice concerns pharmaceutical contracts with an option to accede, covering medicines containing the active substance combinations named in the title. It is not an award of a public contract under Directive 2014/24/EU or German procurement law. The notice is published in the Supplement to the Official Journal of the EU to inform pharmaceutical companies as broadly as possible. The label 'open procedure' results only from the form requirements and does not create any submission to procurement rules. It is a framework contract with an accession option covering various active substances. No estimated value or deadline is stated. Interested pharmaceutical manufacturers may participate.

Description

Die vorliegende Bekanntmachung betrifft nicht die Vergabe eines öffentlichen Auftrags im Sinne der Vergabekoordinierungsrichtlinie (2014/24/EU) bzw. des Kartellvergaberechts. Im Interesse einer möglichst breit angelegten Information der interessierten pharmazeutischen Unternehmer erfolgt diese Bekanntmachung im Supplement zum Amtsblatt der Europäischen Union. Die im Rahmen des vorliegenden Bekanntmachungstextes verwendete Verfahrensbezeichnung "Offenes Verfahren" (Ziffer IV.1.1) ist den Vorgaben des Bekanntmachungsformulars geschuldet. Hiermit sowie mit der Nutzung des Mediums "TED" ist keinerlei Unterwerfung unter vergaberechtliche Regelungen verbunden, deren Geltung kraft Gesetzes bzw. Vergabeordnungen nicht verpflichtend vorgegeben ist. Es handelt sich um einen Rahmenvertrag mit Beitrittsoption, der sich auf diverse Wirkstoffe bezieht. Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

18 open tenders right now

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
Basics GmbH 1 n/a Jul 2026
BG Hexal 1 A Pharma GbR; 089Pharm GmbH; PUREN Pharma GmbH & Co. KG; Micro Labs GmbH; BG Neuraxpharm / Hexal GbR; BG ALIUD / STADAPHARM GbR; Vivanta Generics s.r.o.; Medical Valley Invest AB; DESMA GmbH; axunio Pharma GmbH; Aristo Pharma GmbH; ORION Pharma GmbH; BG TEVA ratiopharm GbR; Pfizer Pharma 1 n/a Aug 2026
BG Hexal 1 A Pharma GbR; Micro Labs GmbH; PUREN Pharma GmbH & Co. KG; Zentiva Pharma GmbH; BG TEVA ratiopharm GbR; HEC Pharm GmbH; BG ALIUD / STADAPHARM GbR; Basics GmbH; Ascend GmbH; Aristo Pharma GmbH; Abanta Pharma GmbH; Dermapharm AG; LEO Pharma GmbH; Viatris Healthcare GmbH, Zweigniederlassung 1 n/a Jul 2026

Based on 3 awards with a linked company profile over the last 5 years.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now February 1, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.
  2. Act now
    • Estimated value: Set to €39,460,247
    • Submission deadline: Moved 1 day EARLIER: now February 1, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.
    • Estimated value: Set to €39,460,247
  3. Act now
    • Submission deadline: Moved 1 day EARLIER: now February 1, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.
  4. Act now
    • Submission deadline: Moved 1 day EARLIER: now February 1, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€9,281,286
11,575 open across Europe right now
Buyer track record on Aperlena
89 notices tracked · 31 awarded
€1,264,701 in awarded contracts

Never miss a tender like this

103 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

499 days left

Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close